Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02392195
Other study ID # IRB-P00004233
Secondary ID
Status Completed
Phase
First received
Last updated
Start date February 2013
Est. completion date September 2020

Study information

Verified date December 2020
Source Boston Children's Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This study will enable investigators to find out if brain structure and characteristics are affected by the shape of the infant's head, and if changes in the brain occur with helmet therapy.


Description:

A dramatic increase in the number of infants diagnosed with Deformational Plagiocephaly (DP) has been observed worldwide since institution of the American Academy of Pediatrics' Back to Sleep Program. According to one published report, the incidence of DP ranges between 3-48%; this translates into120,000-2 million infants/year who develop DP in the United States alone. Some healthcare providers believe that DP is a purely cosmetic condition. This mindset undermines the importance of prevention and correction. In New Zealand, a recent study demonstrated that 39% of children without corrective action had persistent DP at age 3 to 4 years. Additionally, several studies have demonstrated associations between impaired social interactions, developmental problems and DP.Thus some researchers now believe that there may be a spectrum of untoward outcomes from brain remodeling resulting from DP. Recent technological advances now allow the detection of diminutive changes in brain structure. In this multidisciplinary descriptive pilot study we will use brain MRI (Magnetic Resonance Imaging) and a cerebral tissue oxygenation monitor, namely Frequency Domain Near Infrared and Diffuse Correlation Spectroscopy (FDNIR/DCS) to describe if differences in brain structure and characteristics exist in infants with significant DP before and after correction of the deformational defect. This study will enable investigators to seek preliminary evidence that brain development is influenced by the shape of the cranial vault, and that changes in brain structure and characteristics occur with helmet therapy. Additionally this study will help to determine the need for a larger investigation of this phenomenon that would further establish an association between DP and developmental delay.


Recruitment information / eligibility

Status Completed
Enrollment 10
Est. completion date September 2020
Est. primary completion date September 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group N/A to 8 Months
Eligibility Inclusion Criteria: 1. - DP requiring helmet therapy 2. -Term gestation at birth (37 weeks or greater) 3. -Less than/or equal to 8 months of age 4. -No history of major health problem such as birth injury, genetic disorder, intracranial hemorrhage, hydrocephalus, neurologic abnormality 5. -No history of implantable metal device or internal/external orthotic device Exclusion Criteria: 1. - DP not requiring helmet therapy 2. -Premature gestation at birth (less than 37 weeks gestation). 3. -Greater than 8 months of age 4. -History of major health problem such as birth injury genetic disorder, intracranial hemorrhage, hydrocephalus, neurologic abnormality 5. -History of implantable metal device or internal/external orthotic device 6. -Infants not completing prescribed treatment for correction with a helmet

Study Design


Intervention

Other:
Non-interventional
Observational

Locations

Country Name City State
United States Children's Hospital Boston Boston Massachusetts

Sponsors (1)

Lead Sponsor Collaborator
Boston Children's Hospital

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other Number of Participants With Improved Cranial Asymmetry After Cranial Orthotic Treatment Cranial asymmetry was assessed using the Cranial Vault Asymmetry Index (CVAI). MRI's were utilized to determine CVAI. Asymmetry pre treatment was compared to post treatment to see if asymmetry improved. Collected retrospectively
Primary Number of Participants With Qualitatively Determined Normalization of White Matter Pathways We will compare if nerve pathways are appreciably different in the area of head flattening following helmet therapy by visual examination and comparison of areas of asymmetry vs. symmetry. 2-6 months
Secondary Number of Participants With Improved Developmental Exams Post Helmet Therapy The Mullen (Scales of Early Learning) was used to determine developmental scores. This tool provides a profile of cognitive ability in five areas:
Gross Motor, Fine Motor, Expressive Language, Receptive Language, and Visual Reception. Each of the 5 assessment that has a raw score that is then given a percentile rank and descriptive category (below average, average, above average) for interpretation purposes. Descriptive categories pre treatment were compared to post treatment to determine if scores had improved.
2-6 months
See also
  Status Clinical Trial Phase
Completed NCT03970395 - Effectiveness of Osteopathic Manipulative Therapy in Nonsynostotic Plagiocephaly N/A